TIFA Antikörper (AA 1-184) (FITC)
Kurzübersicht für TIFA Antikörper (AA 1-184) (FITC) (ABIN7172334)
Target
Alle TIFA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-184
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human TRAF-interacting protein with FHA domain-containing protein A protein (1-184AA)
-
Isotyp
- IgG
-
-
anti-TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA) (AA 52-79), (N-Term) antibody
TIFA Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB24815 unconjugated
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))
-
Andere Bezeichnung
- TIFA
-
Hintergrund
-
Background: Adapter protein which mediates the IRAK1 and TRAF6 interaction following IL-1 stimulation, resulting in the downstream activation of NF-kappa-B and AP-1 pathways. Induces the oligomerization and polyubiquitination of TRAF6, which leads to the activation of TAK1 and IKK through a proteasome-independent mechanism.
Aliases: Putative MAPK activating protein PM14 antibody, Putative MAPK-activating protein PM14 antibody, Putative NF kappa B activating protein 20 antibody, Putative NF-kappa-B-activating protein 20 antibody, T2BP antibody, TIFA antibody, TIFA_HUMAN antibody, TRAF interacting protein with FHA domain containing protein A antibody, TRAF-interacting protein with FHA domain-containing protein A antibody, TRAF2 binding protein antibody, TRAF2-binding protein antibody
-
UniProt
- Q96CG3
Target
-
